Literature DB >> 10694352

Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes.

I A Buhimschi1, W B Kramer, C S Buhimschi, L P Thompson, C P Weiner.   

Abstract

OBJECTIVE: The mechanisms underlying membrane rupture at term and preterm are obscure. Collagenolytic activity of matrix metalloproteinases in amniochorionic membranes increases during spontaneous term and preterm labor associated with intra-amniotic infection. We sought to test the hypothesis that reduction-oxidation homeostasis, which is altered in inflammatory states, directly regulates amniochorionic matrix metalloproteinases. STUDY
DESIGN: Membranes were collected from 7 patients undergoing elective cesarean delivery at term, rinsed thoroughly, and immediately incubated in phosphate-buffered sodium chloride solution at 37 degrees C for 24 hours. Matrix metalloproteinase activity in the culture medium was assayed by substrate-gel electrophoresis and normalized against the dry weight of the tissue incubated. Superoxide anions were generated in the presence of membranes by a xanthine (2 mmol/L) and xanthine oxidase (20 mU/mL) mixture and monitored by reduction of ferri-cytochrome c to ferro-cytochrome c. Incubations were performed in the presence of xanthine alone, a xanthine-xanthine oxidase mixture, superoxide dismutase (500 U/mL), a xanthine-xanthine oxidase-superoxide dismutase mixture, nitro-L-arginine (a nitric oxide synthase inhibitor, 1 mmol/L), xanthine-xanthine oxidase-nitro-L-arginine, S-nitroso-N -acetylpenicillamine (a nitric oxide donor, 10 mmol/L), xanthine-xanthine oxidase-S-nitroso-N -acetylpenicillamine, N -acetylcysteine (a thiol-containing antioxidant, 0.1, 1, or 10 mmol/L), lipopolysaccharide (100 ng/mL), or lipopolysaccharide-N -acetylcysteine. Intracellular generation of superoxide anions was monitored by the reduction of nitroblue tetrazolium to formazan.
RESULTS: Basal matrix metalloproteinase 9 and matrix metalloproteinase 2 levels were detected in all samples. Superoxide anions significantly increased matrix metalloproteinase 9 activity but did not increase matrix metalloproteinase 2 activity, which effect was reversed by the addition of superoxide dismutase. N-acetylcysteine reduced basal activity of both matrix metalloproteinase 9 and matrix metalloproteinase 2 to 20%. Importantly, N-acetylcysteine completely inhibited intracellular formazan formation in cultured membranes both in the absence and in the presence of lipopolysaccharide. Neither nitric oxide synthase inhibition nor the nitric oxide donor S-nitroso-N -acetylpenicillamine had any effect on fetal membrane matrix metalloproteinase activity.
CONCLUSION: Matrix metalloproteinase activity in human fetal membranes is reduction-oxidation (redox)-regulated. Matrix metalloproteinase 9 activity in human fetal membranes is directly increased by superoxide anion, a byproduct of macrophages and neutrophils. Neither nitric oxide donors nor nitric oxide synthase inhibitors significantly affect matrix metalloproteinase activity in human fetal membranes. The glutathione precursor N-acetylcysteine dramatically inhibits amniochorionic matrix metalloproteinase activity in addition to inhibiting intrinsic superoxide generation within the tissue. Thus thiol-reducing agents, such as N-acetylcysteine, may be beneficial in preventing preterm premature rupture of the membranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694352     DOI: 10.1016/s0002-9378(00)70239-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Mepenzolate bromide promotes diabetic wound healing by modulating inflammation and oxidative stress.

Authors:  Yongjun Zheng; Xingtong Wang; Shizhao Ji; Song Tian; Haibin Wu; Pengfei Luo; He Fang; Li Wang; Guosheng Wu; Shichu Xiao; Zhaofan Xia
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

Review 3.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

Review 4.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

Review 5.  Oxidative stress in pregnancy and reproduction.

Authors:  Kate Duhig; Lucy C Chappell; Andrew H Shennan
Journal:  Obstet Med       Date:  2016-05-17

6.  Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.

Authors:  Irina A Buhimschi; Catalin S Buhimschi; Carl P Weiner; Tatsuji Kimura; Benjamin D Hamar; Anna K Sfakianaki; Errol R Norwitz; Edmund F Funai; Elena Ratner
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

7.  Roles of Progesterone Receptor Membrane Component 1 in Oxidative Stress-Induced Aging in Chorion Cells.

Authors:  Liping Feng; Terrence K Allen; William P Marinello; Amy P Murtha
Journal:  Reprod Sci       Date:  2018-05-21       Impact factor: 3.060

Review 8.  Human fetal membranes at term: Dead tissue or signalers of parturition?

Authors:  Ramkumar Menon
Journal:  Placenta       Date:  2016-05-29       Impact factor: 3.481

9.  Glutathione redox dynamics and expression of glutathione-related genes in the developing embryo.

Authors:  Alicia R Timme-Laragy; Jared V Goldstone; Barry R Imhoff; John J Stegeman; Mark E Hahn; Jason M Hansen
Journal:  Free Radic Biol Med       Date:  2013-06-13       Impact factor: 7.376

Review 10.  Inflammation, leukocytes and menstruation.

Authors:  Jemma Evans; Lois A Salamonsen
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.